Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Aug 30, 2020
Open Peer Review Period: Aug 30, 2020 - Oct 25, 2020
Date Accepted: Oct 25, 2020
Date Submitted to PubMed: Oct 27, 2020
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

The Swiss Prison Study (SWIPS): Protocol for Establishing a Public Health Registry of Prisoners in Switzerland

Gaisl T, Musli N, Baumgartner P, Meier M, Rampini SK, Blozik E, Battegay E, Kohler M, Saxena S

The Swiss Prison Study (SWIPS): Protocol for Establishing a Public Health Registry of Prisoners in Switzerland

JMIR Res Protoc 2020;9(12):e23973

DOI: 10.2196/23973

PMID: 33099459

PMCID: 7755536

The Swiss Prison Study (SWIPS): Protocol for a public health registry among prisoners

  • Thomas Gaisl; 
  • Naser Musli; 
  • Patrick Baumgartner; 
  • Marc Meier; 
  • Silvana K. Rampini; 
  • Eva Blozik; 
  • Edouard Battegay; 
  • Malcolm Kohler; 
  • Shekhar Saxena

ABSTRACT

Background:

Health aspects, disease frequencies, and specific health interests of prisoners and refugees are poorly understood. Importantly, access to the healthcare system is limited for this vulnerable population.

Objective:

Currently, there has been no systematic investigation to understand the health issues of inmates in Switzerland. Furthermore, little is known on how recent migration flows in Europe may have impacted the health conditions of inmates in recent years. We therefore planned a large-scale observational study to establish a public health registry in northern-central Switzerland.

Methods:

Demographic and health-related data, such as age, sex, country of origin, duration of imprisonment, medication (including the drug name, brand, dosage, and release), medical history (including the ICD codes for all diagnoses and external results that are part of the medical history in the prison) will be deposited in a central register over a span of five years (April 2015 to April 2020). The final cohort is expected to comprise approximately 50,000 to 60,000 prisoners from the Police Prison Zurich (PPZ), Switzerland. The primary objective is to establish a central database to assess disease prevalence (i.e., ICD codes) among prisoners. The secondary objectives include the following: (1) to compare the 2015 to 2020 disease prevalence among inmates against a representative sample from the local resident population; (2) to assess longitudinal changes in disease prevalence from 2015 to 2020 using cross-sectional medical records from all inmates at the PPZ; and (3) to identify unrecognized health problems to prepare successful public health strategies.

Results:

The current study was funded in August 2020 by the "Walter and Gertrud Siegenthaler" foundation and the "Theodor and Ida Herzog-Egli" foundation and approved by the IRB in August 2019. Data collection started in August 2019 and results are expected to be published in 2021. Findings will be disseminated through scientific articles as well as presentations and public events.

Conclusions:

None Clinical Trial: ISRCTN registry (www.isrctn.com/ISRCTN11714665)


 Citation

Please cite as:

Gaisl T, Musli N, Baumgartner P, Meier M, Rampini SK, Blozik E, Battegay E, Kohler M, Saxena S

The Swiss Prison Study (SWIPS): Protocol for Establishing a Public Health Registry of Prisoners in Switzerland

JMIR Res Protoc 2020;9(12):e23973

DOI: 10.2196/23973

PMID: 33099459

PMCID: 7755536

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.